Table 4.
Overview of effects of ghrelin in experimental epilepsy models. i.c.v.: intracerebroventricular; i.h.: intrahippocampal; IHKA: intrahippocampal kainic acid; i.p.: intraperitoneal; KA: kainic acid; min: minute; pen: penicillin; pilo: pilocarpine; PTZ: pentylenetetrazole; Ref: reference.
Dose | Administration Regimen |
Anticonvulsant | Animal Model | Ref |
---|---|---|---|---|
0.02–0.08 mg/kg | i.p. 30 min prior to PTZ |
yes | PTZ i.p. rat model | [105,117] |
0.08 mg/kg | i.p. 30 min prior to PTZ |
no | PTZ i.p. rat model | [118] |
0.3 nmol/µL | i.h. infusion 1 x 30 min prior to PTZ or 10 days |
yes | PTZ i.p. rat model | [106,107] |
0.08 mg/kg | i.c.v. 30 min prior to PTZ |
yes | PTZ i.p. rat model (female rats) |
[108] |
0.5, 1 and 2 µg | i.c.v. 30 min after pen |
yes | Intracortical penicillin rat model |
[113,119] |
0.08 mg/kg | i.p., immediate assessment |
no | WAG/Rij rat model | [114] |
0.01–10 µM | i.h. infusion, 120 min prior to pilo | yes | Pilocarpine i.h. infusion rat model |
[116] |
1.5 mg/kg | i.p. 10 min prior to pilo |
no | Pilocarpine i.p. rat model |
[31,115] |
1.5 mg/kg | i.p. 10 min prior to KA |
no | KA i.p. rat model |
[115] |
0.08 mg/kg | i.p. 30 min prior to KA, and 24 h after KA | yes | KA i.p. mouse model |
[29] |
1.8 mg/kg | i.p. 30 min prior to pilo |
yes | Pilocarpine tail infusion mouse model | [116] |